Azzad Asset Management Inc. ADV lifted its stake in shares of National Research Co. (NASDAQ:NRC – Free Report) by 60.8% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 32,939 shares of the company’s stock after buying an additional 12,458 shares during the quarter. Azzad Asset Management Inc. ADV owned about 0.14% of National Research worth $753,000 as of its most recent SEC filing.
A number of other hedge funds also recently modified their holdings of the stock. Kayne Anderson Rudnick Investment Management LLC lifted its stake in shares of National Research by 0.6% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 3,045,306 shares of the company’s stock worth $69,890,000 after buying an additional 18,891 shares during the last quarter. Vanguard Group Inc. raised its stake in National Research by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 944,995 shares of the company’s stock worth $37,431,000 after purchasing an additional 10,351 shares in the last quarter. Renaissance Technologies LLC raised its stake in National Research by 14.4% in the 2nd quarter. Renaissance Technologies LLC now owns 432,884 shares of the company’s stock worth $9,935,000 after purchasing an additional 54,600 shares in the last quarter. Millennium Management LLC raised its stake in National Research by 200.9% in the 2nd quarter. Millennium Management LLC now owns 214,858 shares of the company’s stock worth $4,931,000 after purchasing an additional 143,454 shares in the last quarter. Finally, Norden Group LLC acquired a new stake in National Research in the 1st quarter worth about $5,170,000. Institutional investors and hedge funds own 47.26% of the company’s stock.
National Research Price Performance
Shares of National Research stock opened at $19.49 on Wednesday. National Research Co. has a twelve month low of $19.26 and a twelve month high of $45.49. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 0.64. The company has a 50-day simple moving average of $21.85 and a two-hundred day simple moving average of $26.82. The stock has a market capitalization of $465.36 million, a price-to-earnings ratio of 15.72 and a beta of 0.49.
National Research Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Stockholders of record on Friday, September 27th will be given a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 2.46%. The ex-dividend date is Friday, September 27th. National Research’s payout ratio is presently 38.71%.
National Research Company Profile
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
Featured Stories
- Five stocks we like better than National Research
- Stock Splits, Do They Really Impact Investors?
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- What is the Nasdaq? Complete Overview with History
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- Where Do I Find 52-Week Highs and Lows?
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.